Letizia Mazzini is a full professor of Neurology and Director of the Tertiary ALS Center at the University of Piemonte Orientale. Her main scientific interests lie in the field of basic and clinical research on motor neuron diseases. She has cooperated as an investigator in many multicenter therapeutic trials on ALS. She is the head of the first phase 1 study authorized by the Italian Institute of Health on the clinical application of mesenchymal autologous stem cells in ALS patients, and she is the clinical coordinator of the phase 1 and phase II clinical studies on neural fetal stem cell transplantation in ALS. She is the author or co-author of more than 200 papers published in peer-reviewed journals and books ( H-index: 56 Total number of citations: 10,640 (Scopus) She is a member of the Italian neurological society subgroup on MND, ENCALS (European Network for the Cure of ALS), the European Research Network for Rare Diseases, and the scientific advisory board of the Italian ALS Association.